Stock Track | HAIXI PHARMA Plummets 8.35% Intraday on Lock-up Expiry Selling and Correction from Historical Highs

Stock Track05-04 09:58

HAIXI PHARMA's stock plummeted 8.35% during intraday trading on Monday, marking a significant decline for the pharmaceutical company.

The sharp drop is primarily attributed to ongoing selling pressure following the expiration of the stock's post-IPO lock-up period. The six-month lock-up recently ended, releasing approximately 1.9817 million shares held by cornerstone investors, representing 2.52% of the company's total share capital. This has created substantial selling pressure in the market as these investors are now able to trade their holdings.

Additionally, the stock is experiencing a continued correction from its historical highs. HAIXI PHARMA had nearly doubled in value over the preceding month, reaching a record high of 302.4 HKD before plunging over 25% in a single session. Despite a brief two-day rebound, the overall pattern remains one of high-level consolidation and retreat as the stock corrects from its recent rapid appreciation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181538654?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 09:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181538654","market":"hk","top_or_hot":-1,"title":"Stock Track | HAIXI PHARMA Plummets 8.35% Intraday on Lock-up Expiry Selling and Correction from Historical Highs","media":"Stock Track","content":"<p>HAIXI PHARMA's stock plummeted 8.35% during intraday trading on Monday, marking a significant decline for the pharmaceutical company.</p><p>The sharp drop is primarily attributed to ongoing selling pressure following the expiration of the stock's post-IPO lock-up period. The six-month lock-up recently ended, releasing approximately 1.9817 million shares held by cornerstone investors, representing 2.52% of the company's total share capital. This has created substantial selling pressure in the market as these investors are now able to trade their holdings.</p><p>Additionally, the stock is experiencing a continued correction from its historical highs. HAIXI PHARMA had nearly doubled in value over the preceding month, reaching a record high of 302.4 HKD before plunging over 25% in a single session. Despite a brief two-day rebound, the overall pattern remains one of high-level consolidation and retreat as the stock corrects from its recent rapid appreciation.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | HAIXI PHARMA Plummets 8.35% Intraday on Lock-up Expiry Selling and Correction from Historical Highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | HAIXI PHARMA Plummets 8.35% Intraday on Lock-up Expiry Selling and Correction from Historical Highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 09:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HAIXI PHARMA's stock plummeted 8.35% during intraday trading on Monday, marking a significant decline for the pharmaceutical company.</p><p>The sharp drop is primarily attributed to ongoing selling pressure following the expiration of the stock's post-IPO lock-up period. The six-month lock-up recently ended, releasing approximately 1.9817 million shares held by cornerstone investors, representing 2.52% of the company's total share capital. This has created substantial selling pressure in the market as these investors are now able to trade their holdings.</p><p>Additionally, the stock is experiencing a continued correction from its historical highs. HAIXI PHARMA had nearly doubled in value over the preceding month, reaching a record high of 302.4 HKD before plunging over 25% in a single session. Despite a brief two-day rebound, the overall pattern remains one of high-level consolidation and retreat as the stock corrects from its recent rapid appreciation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02637","symbol_name":"海西新药","start_time":0,"source_url":"","article_id":"1181538654","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181538654","pubTimestamp":1777859931,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"HAIXI PHARMA's stock plummeted 8.35% during intraday trading on Monday, marking a significant decline for the pharmaceutical company.The sharp drop is primarily attributed to ongoing selling pressure...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02637":"海西新药"},"translate_title":"个股赛道|锁定到期抛售回调历史高位海西药业盘中暴跌8.35%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02637":1},"content_text":"HAIXI PHARMA's stock plummeted 8.35% during intraday trading on Monday, marking a significant decline for the pharmaceutical company.The sharp drop is primarily attributed to ongoing selling pressure following the expiration of the stock's post-IPO lock-up period. The six-month lock-up recently ended, releasing approximately 1.9817 million shares held by cornerstone investors, representing 2.52% of the company's total share capital. This has created substantial selling pressure in the market as these investors are now able to trade their holdings.Additionally, the stock is experiencing a continued correction from its historical highs. HAIXI PHARMA had nearly doubled in value over the preceding month, reaching a record high of 302.4 HKD before plunging over 25% in a single session. Despite a brief two-day rebound, the overall pattern remains one of high-level consolidation and retreat as the stock corrects from its recent rapid appreciation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181538654","isCrawlerRequest":true}